Skip to search.
 FTSE 100 Down 0.04%

AbbVie Inc. (ABBV)

-NYSE
60.50 Down 0.02(0.03%) 27 Feb 21:00
|After Hours: : 60.59 Up 0.09 (0.15%) 28 Feb 00:07
Add to Portfolio
Prev Close:60.52
Open:60.53
Bid:60.41 x 200
Ask:60.77 x 200
1y Target Est:68.64
Beta:1.66
Earnings Date:23 Apr - 27 Apr (Est.)
Day's Range:60.37 - 60.99
52wk Range:45.50 - 70.76
Volume:8,649,102
Avg Vol (3m):9,579,380
Market Cap:96.43b
P/E (ttm):55.00
EPS (ttm):1.10
Div & Yield:2.04 (3.40%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVDown 0.03%96.43b
MRKDown 0.71%166.89b
NVSDown 0.58%245.62b
PFEDown 0.78%216.24b

Key Statistics

Forward P/E (1 yr):12.10
P/S (ttm):4.83
Ex-Dividend Date:13-Apr-15

Analysts

Annual EPS Est (Dec-15) :4.39
Quarterly EPS Est (Mar-15) :0.85
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):0.89

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback